Heart disease medications underused among Hispanic/Latino populations with PAD

August 05, 2020

DALLAS, Aug. 5, 2020 -- Recommended medications for peripheral artery disease and coronary artery disease are underused among Hispanic and Latino people, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

Peripheral artery disease, or PAD, causes the arteries, which flow away from the heart, to narrow due to the buildup of plaque, and previous research suggests approximately 8.5 million Americans have PAD. The most common symptom of PAD is pain or tiredness in the legs while walking that goes away with rest. In addition to decreased well-being, PAD can lead to serious complications including leg amputation and other cardiovascular diseases, such as narrowing of the heart's arteries, heart failure or stroke.

The American College of Cardiology/American Heart Association 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic) recommends antiplatelet therapy (low dose aspirin or a blood thinner such as clopidogrel) and cholesterol-lowering statin therapy for PAD patients, as prescribed by a physician. However, limited access to health care among various racial/ethnic groups often results in poorer outcomes for many chronic health conditions including peripheral artery disease. Previous research has shown that the recommended medications are underused among people with peripheral artery disease, in general; however, little information is available about their use among Hispanic and Latino populations.

"Heightened attention and more efforts to improve treatment are needed in the care of PAD patients to prevent future cardiovascular events and leg amputation," said lead author Simin Hua, M.H.Sc., an associate researcher in the department of epidemiology and population health at Albert Einstein College of Medicine in New York City. "These efforts might include improving health care access, educating patients and advocating that physicians offer guideline-adherent treatment. This is especially important because many Hispanic/Latino individuals in the U.S. face issues such as lack of health insurance and high burden of cardiovascular risk factors."

Study participants included 1,244 self-identified Hispanic or Latino adults, between 18-74 years old, in Chicago, Miami, San Diego and in the Bronx borough of New York City. The average age of those with peripheral artery disease was 53; the average age for those with coronary artery disease was 56; and 59% of participants with peripheral artery disease and 42% of those with coronary artery disease were female. Participants had a previous peripheral artery disease diagnosis by a physician in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) from 2008-2011. HCHS/SOL is an ongoing, community-based, prospective study to estimate the burden of cardiovascular disease and other chronic diseases and to identify the associated risk factors among the U.S. Hispanic/Latino populations from six backgrounds, including Dominican, Cuban, Central American, Mexican, Puerto Rican and South American.

During an in-person interview and health examination conducted in English and Spanish, the majority of participants (826) self-reported a peripheral artery disease diagnosis from a doctor, with the remaining participants (418) self-reporting a diagnosis of coronary artery disease alone. Other data collected included highest level of education, socioeconomic status, place of birth (in the U.S. or not), preferred language, health insurance coverage, number of doctor visits in the past year and cardiovascular risk factors (current smoking, hypertension, Type 2 diabetes, high cholesterol and obesity). Participants were instructed to bring to the appointment the medications they had taken within the past month. Based on this information, the investigators calculated the percentage of participants taking medication to lower blood pressure or cholesterol and to prevent blood clots.

Researchers found:

Overall, among patients with PAD: 26% took medications to lower cholesterol and 31% took medications to prevent blood clots;

Yet, among patients with coronary artery disease alone: 42% took medications to lower cholesterol and 47% took medications to prevent blood clots.

Among the 521 patients with both PAD and high blood pressure, 57% were taking medications to reduce their blood pressure; while 68% of the 315 patients with high blood pressure and coronary artery disease took medications to lower their blood pressure.

Compared to other participant subgroups, Hispanics of Mexican background reported the lowest usage of all three classes of cardiovascular medications in the study and were the least likely to have health insurance.

"The need for medications did not seem to receive the same level of attention for patients with PAD compared to those with coronary artery disease, even though both patient groups can benefit from these cardiovascular medications," Hua said.

Researchers noted several limitations could have affected the study's results. For example, the study did not include any participants who did not self-identify as Hispanic or Latino for comparison. It also did not include information about any medication usage over time, or whether participants were not prescribed medications or were not taking their prescribed medications. In addition, study participants could have inaccurately self-reported their PAD diagnosis.
-end-
Co-authors are Carmen R. Isasi, M.D., Ph.D.; Jorge R. Kizer, M.D., M.Sc.; Kunihiro Matsushita, M.D., Ph.D.; Matthew A. Allison, M.D., M.P.H.; Wassim Tarraf, Ph.D.; Qibin Qi, Ph.D.; Sonia G. Ponce, M.D., M.P.H.; Martha Daviglus, M.D., Ph.D.; and Robert C. Kaplan, Ph.D.

The National Heart, Lung, and Blood Institute of the National Institutes of Health supported the study.

Additional Resources:

Available multimedia is on right column of release link - https://newsroom.heart.org/news/heart-disease-medications-underused-among-hispaniclatino-populations-with-pad?preview=402c3acec429bea65d55a6f2028685a0

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

American Heart Association

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.